形态测量胚胎细胞评估:一项回顾性研究,检查胚胎细胞直径和面积与辅助生殖技术周期中的妊娠结果之间的关系
Romualdo Sciorio1,2, Pier Francesco Greco3, Luca Tramontano4
1Fertility Medicine and Gynaecological Endocrinology Unit, Department Woman Mother Child, Lausanne University Hospital, 1011 Lausanne, Switzerland.
Journal of clinical medicine
|April 26, 2025
概括
用面积和直径来衡量胚芽细胞大小,可以显著预测辅助生殖技术 (ART) 中的怀孕成功. 较大的胚芽细胞与更高的植入率和持续妊娠率相关,有助于胚胎选择.
科学领域:
- 生殖生物学 生殖生物学
- 胚胎学 胚胎学
- 辅助生殖技术 (ART) 是一种助孕技术.
背景情况:
- 在ART中成功怀孕取决于优化胚胎培养和选择可行的胚胎.
- 预测植入潜力对于改善ART结果至关重要.
- 胚胎囊的形态测量分析为胚胎评估提供了客观的措施.
研究的目的:
- 在ART中调查胚胎囊面积和直径以及怀孕结果之间的相关性.
- 为了确定胚胎细胞形态学是否可以预测植入和正在进行的怀孕率.
- 评估在胚胎选择中客观胚胎囊测量的实用性.
主要方法:
- 对665名接受ART治疗的患者进行回顾性分析,在第5天进行单个胚胎囊移植.
- 测量胚胎囊面积 (μm2) 和直径 (μm).
- 统计分析以将形态特征与植入率 (IR) 和正在进行的临床怀孕率 (CPR) 相关联.
主要成果:
- 囊胞面积 (≥25,000微米2) 和直径 (≥170微米) 都与更高的IR和CPR显著相关.
- 与较小的胚胎相比,具有较大面积的胚胎显示出显著更高的IR (69.8%) 和CPR (65.5%),IR: 47.9%,CPR: 45.9%).
- 大直径的胚胎显示显著更高的IR (68.8%) 和CPR (66.3%) 与较小的胚胎相比 (IR: 36.6%,CPR: 35.7%).
结论:
- 胚胎细胞形态学变量 (面积和直径) 是胚胎生存能力的客观和可靠预测因素.
- 这些测量可以帮助胚胎学家选择具有更高植入潜力的胚胎.
- 客观的胚胎囊评估可以提高正在进行的怀孕成功率在ART.
相关概念视频
Cleavage and Blastulation
44.4K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
44.4K
In Vitro Fertilization
150
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
150
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K


